Philip H Hwang
About Me
Philip Hwang is a current PhD student in the Neurobiology multidisciplinary training area at the Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai. Philip is a member of Schaefer Lab where he focuses on the epigenetic regulation of neuronal states.
Philip graduated from the University of California, Irvine in 2018 with a Bachelor of Science degree in Neurobiology.
Language
Position
Research Topics
Epigenetics, Neurobiology, Neuroscience
Multi-Disciplinary Training Areas
Neuroscience [NEU]
About Me
Philip Hwang is a current PhD student in the Neurobiology multidisciplinary training area at the Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai. Philip is a member of Schaefer Lab where he focuses on the epigenetic regulation of neuronal states.
Philip graduated from the University of California, Irvine in 2018 with a Bachelor of Science degree in Neurobiology.
Language
Position
Research Topics
Epigenetics, Neurobiology, Neuroscience
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Education
BS, University of California, Irvine
Locations
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. HWANG has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. HWANG has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.